Clinical trial
Seizure Therapy With Intravenous Levetiracetam and Lorazepam
NCT00465244 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Seizure Therapy With Intravenous Levetiracetam and Lorazepam
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- January 31, 2008
- Completion date
- May 31, 2010
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.